The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Randomized, Controlled Trial of Topical Exit-Site Application of Honey (Medihoney) versus Mupirocin for the Prevention of Catheter-Associated Infections in Hemodialysis Patients
Abstract
The clinical usefulness of hemodialysis catheters is limited by increased infectious morbidity and mortality. Topical antiseptic agents, such as mupirocin, are effective at reducing this risk but have been reported to select for antibiotic-resistant strains. The aim of the present study was to determine the efficacy and the safety of exit-site application of a standardized antibacterial honey versus mupirocin in preventing catheter-associated infections. A randomized, controlled trial was performed comparing the effect of thrice-weekly exit-site application of Medihoney versus mupirocin on infection rates in patients who were receiving hemodialysis via tunneled, cuffed central venous catheters. A total of 101 patients were enrolled. The incidences of catheter-associated bacteremias in honey-treated (n = 51) and mupirocin-treated (n = 50) patients were comparable (0.97 versus 0.85 episodes per 1000 catheter-days, respectively; NS). On Cox proportional hazards model analysis, the use of honey was not significantly associated with bacteremia-free survival (unadjusted hazard ratio, 0.94; 95% confidence interval, 0.27 to 3.24; P = 0.92). No exit-site infections occurred. During the study period, 2% of staphylococcal isolates within the hospital were mupirocin resistant. Thrice-weekly application of standardized antibacterial honey to hemodialysis catheter exit sites was safe, cheap, and effective and resulted in a comparable rate of catheter-associated infection to that obtained with mupirocin (although the study was not adequately powered to assess therapeutic equivalence). The effectiveness of honey against antibiotic-resistant microorganisms and its low likelihood of selecting for further resistant strains suggest that this agent may represent a satisfactory alternative means of chemoprophylaxis in patients with central venous catheters.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, prevention of exit site infection by coating catheters with honey was found to be at least as effective as povidone iodine [254] or mupirocin [255].”
From Candida glabrata Biofilms: How Far Have We Come? (2017) · cites this paper as [255]
Citations
Cites
A Semiquantitative Culture Method for Identifying Intravenous-Catheter-Related Infection
Maki, D. G., Weise, C. E., & Sarafin, H. W. (1977) · New England Journal of Medicine · doi:10.1056/nejm197706092962301 · Cited by 2,052
Kennedy, C. O. (1971) · British Homeopathic journal · doi:10.1016/s0007-0785(71)80027-3 · Cited by 976
Type of vascular access and mortality in U.S. hemodialysis patients
Dhingra, R. K., Young, E. W., Hulbert‐Shearon, T. E., Leavey, S. F., & Port, F. K. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00947.x · Cited by 760
Maki, D. G., Stolz, S. M., Wheeler, S., & Mermel, L. A. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-4-199708150-00001 · Cited by 748
Marr, K. A., Sexton, D. J., Conlon, P. J., Corey, G. R., Schwab, S. J., & Kirkland, K. B. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-4-199708150-00003 · Cited by 508
Honey stimulates inflammatory cytokine production from monocytes
Tonks, A. (2003) · Cytokine · doi:10.1016/s1043-4666(03)00092-9 · Cited by 470
Vascular access and increased risk of death among hemodialysis patients
Pastan, S. O., Soucie, J. M., & McClellan, W. M. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00460.x · Cited by 451
Vascular Access and All-Cause Mortality
Polkinghorne, K. R., McDonald, S. P., Atkins, R. C., & Kerr, P. G. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000109668.05157.05 · Cited by 431
The sensitivity to honey of Gram-positive cocci of clinical significance isolated from wounds
Cooper, R. A., Molan, P. C., & Harding, K. G. (2002) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.2002.01761.x · Cited by 416
Zumla, A. I., & LULAT, A. G. I. (1989) · Journal of the Royal Society of Medicine · doi:10.1177/014107688908200704 · Cited by 357
Cited by
Sorted by citations
KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update
Lok, C. E., Huber, T. S., Lee, T., Shenoy, S., Yevzlin, A. S., Abreo, K., Allon, M., Asif, A., Astor, B. C., Glickman, M. H., et al. (2020) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2019.12.001 · Cited by 2,590
Vatansever, F., Melo, W., Avci, P., Vecchio, D., Sadasivam, M., Gupta, A., Chandran, R., Karimi, M., Parizotto, N. A., Yin, R., et al. (2013) · FEMS Microbiology Reviews · doi:10.1111/1574-6976.12026 · Cited by 1,157
Honey as a topical treatment for wounds
Jull, A., Cullum, N. A., Dumville, J. C., Westby, M. J., Deshpande, S., & Walker, N. K. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005083.pub4 · Cited by 573
Traditional and modern uses of natural honey in human diseases: a review.
Eteraf-Oskouei, T., & Najafi, M. (2013) · Europe PMC (PubMed Central) · Cited by 456
The Evidence Supporting the Use of Honey as a Wound Dressing
Molan, P. C. (2006) · The International Journal of Lower Extremity Wounds · doi:10.1177/1534734605286014 · Cited by 446
Metadata
- Authors
- Johnson, D. W., van Eps, C., Mudge, D. W., Wiggins, K. J., Armstrong, K., Hawley, C. M., Campbell, S. B., Isbel, N. M., Nimmo, G. R., & Gibbs, H.
- Affiliations
- The University of Queensland (AU)
- Corresponding author
- Johnson, David Wayne
- ORCID
- Venue
- Journal of the American Society of Nephrology
- Published
- 2005-05
- Volume
- 16
- Issue
- 5
- Pages
- 1456-1462
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2139683791
- Cited by
- 162
- References
- 41
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 6 · 2023: 5 · 2022: 4 · 2021: 3 · 2020: 8 · 2019: 6 · 2018: 4 · 2017: 2 · 2016: 9 · 2015: 10 · 2014: 7 · 2013: 13 · 2012: 10
- FWCI
- 15.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of the American Society of Nephrology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Smith and Nephew
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Central Venous Catheters and Hemodialysis
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Health Sciences › Medicine › Urology › Urinary Tract Infections Management
- Keywords
- honey, mupirocin, catheter exit site infection, catheter-related bacteremia, hemodialysis catheter, central venous catheters, antibiotic resistance, topical antibiotics, infection control, staphylococcal isolates
- MeSH terms
- Adult, Aged, Anti-Bacterial Agents, Bandages, Catheterization, Central Venous, Female, Renal Dialysis, Honey, Humans, Kidney Failure, Chronic, Male, Middle Aged, Risk Factors, Bacteremia, Drug Costs, Mupirocin, Disease-Free Survival
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review